Legal Parivar

Legal Parivar is a premier compliance management platform, ensuring legal excellence and seamless adherence to regulations.

Contact Info

Learn More

Follow Us

Read More

Singapore’s GIC Invests Heavily in Data Infrastructure Trust; RJ Corp Boosts Stake in Global Health

Singaporean sovereign wealth fund GIC made a significant investment in Data Infrastructure Trust, acquiring shares worth Rs 5,747.04 crore. GIC, acting through its subsidiary Anahera Investment PTE, purchased 37,44,00,000 shares at a price of Rs 153.5 per share in the Infrastructure Investment Trust (InvIT). BCI IRR India Holdings Inc also participated in the investment, purchasing […]

Eris Lifesciences
Read More

Eris Lifesciences Acquires 51% Stake in Swiss Parenterals for Rs 637.50 Crore, Expanding Sterile Injectables Portfolio and Overseas Reach

Eris Lifesciences Ltd., a prominent player in the Indian pharmaceutical industry, has announced the acquisition of a 51 percent equity stake in Swiss Parenterals Ltd. for Rs 637.50 crore, expanding its presence in sterile injectables. This move marks Eris’s entry into RoW Export Markets. Amit Bakshi, Chairman & Managing Director of Eris Lifesciences Ltd., expressed […]

Read More

JSW Steel Partners with JFE Steel to Establish JV for Grain Oriented Electrical Steel Production in India

JSW Steel Limited has unveiled a partnership with JFE Steel Corporation, Japan, to establish JSW JFE Electrical Steel Private Limited, a firm dedicated to manufacturing Grain Oriented Electrical Steel in India. Situated in District Bellary, Karnataka, the manufacturing facility represents a planned investment of Rs 5500 crores. A groundbreaking ceremony was held on February 12, […]

Read More

Abbott India Shares Surge 9% Following Strong Q3 Earnings

Abbott India witnessed a 9% surge in its shares during morning trading on February 2 after announcing robust earnings for the December quarter. The company reported a net profit of Rs 311 crore in Q3, marking a 26% YoY increase. Despite the adverse impact of including key drugs in the government’s essential medicines list, which […]